Novozymes A/S provided earnings guidance for the year 2022. For the year, the company expects a strong first half and good momentum across the business leading to a narrowed organic sales growth outlook from 4-8% to now 6-8%. Sales reported in Danish kroner expected to be around 8 percentage points higher than the organic sales growth rate.